Is your child currently experiencing ulcerative colitis flare-ups? Local CD clinical trial is testing a potential new medication to see if it may reduce chronic diarrhea, inflammation of the bowel or intestine, diarrhea, malnutrition, and/or eye pain associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the CD clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

Is your child currently experiencing ulcerative colitis flare-ups? Local clinical research is testing a potential new medication to see if it may reduce abdominal pain, inflammation of the bowel or intestine, abdominal pain, malnutrition, and/or anemia associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for children to join a Crohn’s disease research to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or ulcerative colitis (including associated symptoms such as abdominal pain, fever, cramps, malnutrition and/or joint pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing moderate to severe IBD flare-ups? Local study is testing a potential new medication to see if it may reduce diarrhea with pus, fistula, bloody stool, weight loss, and/or anemia associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

Is your child currently experiencing moderate to severe CD flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce bloody diarrhea, mouth sores, rectal pain, malnutrition, and/or eye pain associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local CD research study is testing a potential new medication to see if it may reduce rectal pain, growth failure, bloody stool, weight loss, and/or canker sores associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the CD research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people at least 2 years of age but under 18 to join a clinical research to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or IBD (including associated symptoms such as abdominal cramps, failure to thrive, abdominal pain, frequent fevers and/or liver disease), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local CD clinical trial is testing a potential new medication to see if it may reduce abdominal pain or cramping, abdominal cramps, bloody stool, weight loss, and/or canker sores associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the CD clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease (CD) clinical trial is testing a potential new medication to see if it may reduce painful joints, growth failure, cramps, malnutrition, and/or anemia associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease (CD) clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease (CD) study is testing a potential new medication to see if it may reduce abdominal pain, fever, rectal pain, weight loss, and/or eye pain associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease (CD) study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.